REPR

Repro Med Systems (REPR)

Repro Med Systems Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:REPR

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/05/27	01 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPR	Repro Med Systems Inc
2020/05/21	19 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:REPR	Repro Med Systems Inc
2020/05/14	21 : 40	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:REPR	Repro Med Systems Inc
2020/05/14	21 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPR	Repro Med Systems Inc
2020/05/12	06 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPR	Repro Med Systems Inc
2020/05/08	06 : 05	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:REPR	Repro Med Systems Inc
2020/05/07	05 : 34	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:REPR	Repro Med Systems Inc
2020/05/05	21 : 30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/30	21 : 18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/25	05 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/15	05 : 51	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/02	06 : 34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/02	05 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/02	05 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/02	05 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/02	05 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/02	05 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/02	05 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPR	Repro Med Systems Inc
2020/04/01	02 : 55	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:REPR	Repro Med Systems Inc
2020/03/13	06 : 08	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:REPR	Repro Med Systems Inc
2020/03/12	19 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:REPR	Repro Med Systems Inc
2020/03/07	06 : 12	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:REPR	Repro Med Systems Inc
2020/03/05	07 : 11	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:REPR	Repro Med Systems Inc
2020/03/05	06 : 58	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:REPR	Repro Med Systems Inc
2020/02/26	06 : 56	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:REPR	Repro Med Systems Inc
2020/02/26	06 : 51	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPR	Repro Med Systems Inc
2020/02/15	07 : 09	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:REPR	Repro Med Systems Inc
2020/01/30	07 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPR	Repro Med Systems Inc
2020/01/30	07 : 17	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:REPR	Repro Med Systems Inc
2020/01/25	06 : 40	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:REPR	Repro Med Systems Inc